default author photo

Chaohui Xiao

Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery

SCHOLARLY PAPERS

2

DOWNLOADS

144

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Assessing the Influence of Immune Cell Traits on Hepatocellular Carcinoma Pathogenesis: A Mendelian Randomization Investigation

Number of pages: 21 Posted: 31 Oct 2023
Yan Xu, Fang Sun, Chaohui Xiao, Rong Liu and Penghui Yang
Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery and Government of the People's Republic of China - Institute of Hepatobiliary Surgery
Downloads 83 (783,685)

Abstract:

Loading...

immune cell, Hepatocellular carcinoma, Mendelian randomization, Causal inference.

2.

Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 Infection

Number of pages: 19 Posted: 22 May 2023
Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery, Government of the People's Republic of China - Department of Hepatobiliary Surgery, Government of the People's Republic of China - Department of Hepatobiliary Surgery, Xingtai People's Hospital - Department of Hepatobiliary Surgery, Xingtai People's Hospital - Department of Hepatobiliary Surgery, Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery and Government of the People's Republic of China - Department of Pancreatic Hepatobiliary Surgery
Downloads 61 (951,658)

Abstract:

Loading...

SARS-CoV-2, hepatocellular carcinoma, anti-HBV therapy, IL-2, T cell, prognosis